Saturday, May 16, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

BrainChip Secures Key Licensing Agreement for Akida-2 Technology

Rodolfo Hanigan by Rodolfo Hanigan
March 31, 2026
in AI & Quantum Computing, Semiconductors, Tech & Software, Trading & Momentum
0
BrainChip Stock
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

The neuromorphic computing specialist BrainChip has announced a significant commercial milestone, signaling a potential turnaround after a prolonged period of limited news. The company entered into a global licensing agreement with EDGEAI over the weekend, granting access to its next-generation Akida-2 technology. This deal reinforces a fundamental recovery that was initially hinted at in the firm’s latest annual revenue figures.

Under the terms of the non-exclusive partnership, EDGEAI receives comprehensive access to the intellectual property underpinning BrainChip’s Akida architecture. The agreement also includes necessary development tools and software components. Financial returns for BrainChip will come through milestone-based payments linked to technical delivery targets. Once EDGEAI begins commercial shipment of its own products, quarterly royalty payments will commence. While management has not yet quantified the precise financial scope, it anticipates substantial long-term revenue streams from resulting product sales.

Should investors sell immediately? Or is it worth buying BrainChip?

Financial Performance Shows Marked Improvement

This new contract aligns with a broader positive shift in the company’s financial trajectory. The annual report for 2025, published in late February, revealed a dramatic 374 percent surge in revenue to $1.89 million. Concurrently, BrainChip managed to narrow its net loss from $24.43 million to $20.47 million. The company also strengthened its balance sheet, with cash reserves growing to $31.71 million. Investor sentiment has responded with cautious optimism. The equity, currently trading at €0.09, is attempting to stabilize following an approximate 28 percent decline over the preceding twelve-month period.

Operational Milestones on the Horizon

Beyond commercial deals, operational execution is now coming into focus. The company reports that its AKD1500 chip has entered the volume production phase, with final silicon expected in the third quarter of 2026. In parallel, development has commenced on the custom AKD2500 project. First prototypes for this chip are also slated for availability in Q3 2026. These technological advancements form the foundation for BrainChip to more broadly address rising demand for ultra-low-power AI applications within the edge computing sector.

Ad

BrainChip Stock: Buy or Sell?! New BrainChip Analysis from May 16 delivers the answer:

The latest BrainChip figures speak for themselves: Urgent action needed for BrainChip investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 16.

BrainChip: Buy or sell? Read more here...

Tags: BrainChip
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Kontron Stock
Mergers & Acquisitions

Kontron’s Defense Boom Masks a Cash Drain That Only a Sale Can Fix

May 16, 2026
Alphabet Stock
AI & Quantum Computing

Alphabet’s $3.6 Billion Samurai Bond and Cloud Surge Signal Confidence in AI Bet

May 15, 2026
Palantir Stock
AI & Quantum Computing

Palantir’s Record Quarter Meets a Wall of Worry: Yields, Valuation, and Insider Sales Eclipse a Ukraine Showcase

May 14, 2026
Next Post
Nexus Uranium Stock

Nexus Uranium Shifts Focus to Project Exploration Following Strategic Acquisitions

Orsted Stock

Bank of America Upgrade Ignites Surge in Ørsted Shares

Roche Stock

Roche's Diagnostic Division Gains Momentum with Dual Regulatory Wins

Recommended

Nio Stock

Nio’s Strategic Pivot Sparks Divergent Market Reactions

9 months ago
Technology Robotics Stock Market Today

Analysts Bullish on Qifu Technologys Growth Prospects

2 years ago
Synopsys Stock

Leadership Turmoil Compounds Synopsys’ Mounting Challenges

6 months ago
Yum China Stock

Can Yum China’s Shareholder Returns Strategy Revive Its Stock?

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Triple-Leveraged Silver ETC Hit by 31% Rout as Macro Headwinds Drown Out a Sturdy Deficit

Metaplanet Smashes Revenue Records Yet Posts $725M Loss as Japanese Regulations Stall Key Funding Plan

Kontron’s Defense Boom Masks a Cash Drain That Only a Sale Can Fix

The Shovel Sellers Are Winning the AI Gold Rush

Take-Two Interactive: Losses Hit $4 Billion, but GTA VI Pre-Order Leak Spurs 11% Rally Ahead of Earnings

D-Wave Quantum’s $42 Million Backlog and $588 Million War Chest Set the Stage for a Pivotal June

Trending

Marvell Technology Stock

Marvell’s Optical Ambition and Insider Moves Create a Tale of Two Narratives

by SiterGedge
May 16, 2026
0

Marvell Technology is walking a tightrope between a towering long-term growth story and near-term market pressures that...

Intel Stock

Intel’s Shareholder Mandate and Apple’s Limited Foundry Role: A Tale of Two Realities

May 16, 2026
Rolls-Royce Stock

Rolls-Royce Grounds a Hydrogen Milestone as Geopolitical Headwinds Rattle Aviation Sentiment

May 16, 2026
WisdomTree Silver 3x Daily Leveraged Stock

Triple-Leveraged Silver ETC Hit by 31% Rout as Macro Headwinds Drown Out a Sturdy Deficit

May 16, 2026
Metaplanet Stock

Metaplanet Smashes Revenue Records Yet Posts $725M Loss as Japanese Regulations Stall Key Funding Plan

May 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Marvell’s Optical Ambition and Insider Moves Create a Tale of Two Narratives
  • Intel’s Shareholder Mandate and Apple’s Limited Foundry Role: A Tale of Two Realities
  • Rolls-Royce Grounds a Hydrogen Milestone as Geopolitical Headwinds Rattle Aviation Sentiment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com